PUBLICATION

Modeling leukemia with zebrafish (Danio rerio): Towards precision medicine

Authors
Yi, Z.N., Chen, X.K., Ma, A.C.
ID
ZDB-PUB-221029-10
Date
2022
Source
Experimental cell research   421(2): 113401 (Review)
Registered Authors
Chen, Xiangke, Ma, Alvin
Keywords
Disease modeling, Genetic heterogeneity, Genetic manipulation, Leukemia, Personalized medicine, Zebrafish
MeSH Terms
  • Animals
  • Disease Models, Animal
  • Humans
  • Leukemia*/genetics
  • Leukemia*/pathology
  • Neoplasms*
  • Precision Medicine
  • Zebrafish/genetics
PubMed
36306826 Full text @ Exp. Cell Res.
Abstract
Leukemia is a type of blood cancer characterized by high genetic heterogeneity and fatality. While chemotherapy remains the primary form of treatment for leukemia, its effectiveness was profoundly diminished by the genetic heterogeneity and cytogenetic abnormalities of leukemic cells. Therefore, there is an unmet need to develop precision medicine for leukemia with distinct genetic backgrounds. Zebrafish (Danio rerio), a freshwater fish with exceptional feasibility in genome editing, is a powerful tool for rapid human cancer modeling. In the past decades, zebrafish have been adopted in modeling human leukemia, exploring the molecular mechanisms of underlying genetic abnormalities, and discovering novel therapeutic agents. Although many recurrent mutations of leukemia have been modeled in zebrafish for pathological study and drug discovery, its great potential in leukemia modeling was not yet fully exploited, particularly in precision medicine. In this review, we evaluated the current zebrafish models of leukemia/pre-leukemia and genetic techniques and discussed the potential of zebrafish models with novel techniques, which may contribute to the development of zebrafish as a disease model for precision medicine in treating leukemia.
Genes / Markers
Figures
Expression
Phenotype
Mutations / Transgenics
Human Disease / Model
Sequence Targeting Reagents
Fish
Antibodies
Orthology
Engineered Foreign Genes
Mapping